← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Infixion Bioscience, Inc.
Escondido, CA
$1,727,756
Total funding
3
Grants
Funding over time
peak $595.3K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$1,727,756 · 3
By mechanism
R43$1,727,756 · 3
Investigators at Infixion Bioscience, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Steric-blocking AntiSense Oligonucleotide (ASO) Discovery to Selectively Correct NF1 Haploinsufficiency$339,520
R43 · FY2022 · NS
Inhibition of NF1 Protein Degradation as a Treatment for NF1 Haploinsufficiency$338,722
R43 · FY2021 · NS
Increasing NF1 Expression as a Treatment for NF1 Haploinsufficiency$299,503
R43 · FY2020 · NS
Steric-blocking AntiSense Oligonucleotide (ASO) Discovery to Selectively Correct NF1 Haploinsufficiency$154,078
R43 · FY2023 · NS
Increasing NF1 Expression as a Treatment for NF1 Haploinsufficiency$150,794
R43 · FY2021 · NS
Inhibition of NF1 Protein Degradation as a Treatment for NF1 Haploinsufficiency$143,781
R43 · FY2022 · NS
Steric-blocking AntiSense Oligonucleotide (ASO) Discovery to Selectively Correct NF1 Haploinsufficiency$100,465
R43 · FY2023 · NS
Steric-blocking AntiSense Oligonucleotide (ASO) Discovery to Selectively Correct NF1 Haploinsufficiency$56,254
R43 · FY2023 · NS
Increasing NF1 Expression as a Treatment for NF1 Haploinsufficiency$53,803
R43 · FY2021 · NS
Increasing NF1 Expression as a Treatment for NF1 Haploinsufficiency$52,000
R43 · FY2021 · NS
Steric-blocking AntiSense Oligonucleotide (ASO) Discovery to Selectively Correct NF1 Haploinsufficiency$38,836
R43 · FY2023 · NS